Kenalog (triamcinolone) suspension for injections 40 mg/ml. ampoules 1ml. N5

Description

Allergic reactions, including neurodermatitis, bullous dermatitis, hypersensitivity reactions to drugs, serum sickness. In anaphylactic reactions, corticosteroids should not be used to treat the acute condition, but they can be effective in preventing the last stage of an allergic reaction.
Rheumatic diseases, especially severe rheumatoid arthritis, if necessary to achieve a beneficial effect of long-acting antirheumatic drugs. Corticosteroids are indicated for the short-term treatment of extra-articular rheumatism (epicondylitis, post-traumatic osteoarthritis, synovitis, bursitis) and psoriatic arthritis. At the last indication corticosteroids are recommended in case of exacerbation and as supportive therapy.
Dermatology diseases: herpetiform bullous dermatitis, exfoliative dermatitis, severe polymorphic erythema, severe psoriasis, severe seborrheic dermatitis, eczema, discoid lupus, focal alopecia and various acute and chronic dermatoses.
Ophthalmic diseases: severe acute and chronic allergic and inflammatory conditions, including allergic conjunctivitis, allergic marginal ulcers of the cornea, inflammation of the anterior segment of the eye, chorioretinitis, diffuse posterior uveitis and chorioiditis, shingles, gingivitis, shingles, sympathetic ophthalmia.
Endocrine diseases: primary and secondary insufficiency of adrenal cortex, congenital adrenal hyperplasia, hypercalcemia, malignancy, subacute thyroiditis and Addison’s disease.
Diseases of the digestive system: regional enteritis (Crohn’s disease) and ulcerative colitis during the exacerbation.
Respiratory tract diseases: aspiration pneumonitis, berylliosis, Lefler’s syndrome, sarcoidosis and acute miliary tuberculosis.
Other diseases: Tuberculous meningitis, multiple sclerosis (corticosteroids are used to treat exacerbation of multiple sclerosis; they reduce the duration of exacerbation but do not stop the progression of the disease).